A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...

This comes after both Maccabi and Meuhedet Health Services announced the same subsidy for the Mounjaro weight loss shot.

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the ...

Ozempic and Wegovy, used for diabetes and weight loss, show a link to NAION, a rare eye disorder causing blindness. A study ...

Wegovy provided new insights into their effectiveness, making the choice slightly clearer. The findings? Zepbound led to an average weight loss of 20.2 percent compared to Wegovy's 13.7 percent.

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...